MetLife Investment Management’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$732K Buy
31,071
+4,664
+18% +$110K ﹤0.01% 1477
2025
Q1
$634K Sell
26,407
-396
-1% -$9.51K ﹤0.01% 1598
2024
Q4
$1.13M Buy
26,803
+4,025
+18% +$170K 0.01% 1348
2024
Q3
$1.01M Hold
22,778
0.01% 1384
2024
Q2
$824K Buy
22,778
+2,125
+10% +$76.9K ﹤0.01% 1445
2024
Q1
$891K Buy
20,653
+2,434
+13% +$105K 0.01% 1362
2023
Q4
$280K Hold
18,219
﹤0.01% 2045
2023
Q3
$250K Hold
18,219
﹤0.01% 2077
2023
Q2
$292K Buy
18,219
+9,338
+105% +$150K ﹤0.01% 2031
2023
Q1
$68.9K Hold
8,881
﹤0.01% 2676
2022
Q4
$172K Hold
8,881
﹤0.01% 2343
2022
Q3
$189K Hold
8,881
﹤0.01% 2331
2022
Q2
$121K Hold
8,881
﹤0.01% 2632
2022
Q1
$209K Buy
+8,881
New +$209K ﹤0.01% 2331